The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the body’s natural immune system as well as some therapies. A new study uses novel ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

Scientists are nearing a breakthrough in using CRISPR gene-editing to eliminate HIV from human DNA. Early trials of EBT-101 ...

HIV prevention drug Lenacapavir, which has been tested in South Africa during clinical trials, will be made available in the country in 2026 for high-risk groups.

Scientists have found a breakthrough in the search for a cure for HIV, after research uncovered a development “previously thought impossible”. HIV can ‘hide’ itself in white blood cells, meaning the ...

The "miracle tool" HIV medicine lenacapavir will be sold in South Africa from as early as March or April 2026 according to gov.

In July 2024, we published a story with the headline: "One of the 7 people cured of HIV tells his story. Can his cure work for others." This summer, at the International AIDS Society conference, came ...

"Cure" was the fresh buzzword among researchers at the XIX International AIDS Conference. It was the focus of a two-day pre-conference workshop and a new initiative by the International AIDS Society ...

A London man with long-term undetectable HIV despite stopping antiretroviral treatment a year and a half ago could potentially be the second case of an HIV cure, according to a report at the ...

The National Institutes of Health will distribute approximately $30 million annually over the next five years to six research coalitions working to find a cure for HIV. While medical advances in ...

A major hurdle to curing people of HIV infection is the way the virus hides in a reservoir composed primarily of dormant immune cells. It is generally believed that HIV does not replicate in these ...